Picture of Integra LifeSciences Holdings logo

IART — Integra LifeSciences Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Brief: FDA Says Integra Lifesciences Identified Packaging Failures Related To Medihoney Wound & Burn Products & CVS Wound Gel Products

Jan 22 (Reuters) - FDA:

FDA: INTEGRA LIFESCIENCES IDENTIFIED PACKAGING FAILURES RELATED TO MEDIHONEY WOUND & BURN PRODUCTS THAT COULD LEAD TO A BREACH IN THE STERILE BARRIER

FDA:INTEGRA LIFESCIENCES IDENTIFIED PRODUCTION AND PROCESS CONTROL ISSUES FOR CERTAIN CVS WOUND GEL PRODUCTS

FDA:AS OF DECEMBER 19, 2025, INTEGRA LIFESCIENCES HAS REPORTED 11 SERIOUS INJURIES RELATED TO MEDIHONEY WOUND AND BURN PRODUCTS

FDA:AS OF DECEMBER 19, 2025, INTEGRA LIFESCIENCES HAS REPORTED THREE SERIOUS INJURIES RELATED TO CVS WOUND GEL PRODUCTS

FDA:AS OF DECEMBER 19, 2025, INTEGRA LIFESCIENCES HAS REPORTED NO DEATHS ASSOCIATED WITH MEDIHONEY WOUND AND BURN PRODUCTS & CVS WOUND GEL PRODUCTS

Source text: [ID:]

Further company coverage: IART.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Integra LifeSciences Holdings

See all news